Bristol-Myers Squibb Company
Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter
Published in Hepatitis Weekly, November 2nd, 2009
"The performance in the third quarter of 2009 clearly shows the results of our outstanding business performance, disciplined financial management and overall strategic execution," said James M. Cornelius, chairman and chief executive officer. "We are transforming Bristol-Myers Squibb into a BioPharma leader and the recent approval and launch of ONGLYZA for the treatment of type 2 diabetes is a great example of what we do best: discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
"As part of our...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-11-02)
More Articles from Hepatitis Weekly
- Wiley-Blackwell
Drinking coffee slows progression of liver disease in chronic hepatitis C sufferers - Wiley-Blackwell
Scientists identify specific markers that trigger aggressiveness of liver cancer - Carcinoma
New carcinoma study findings have been reported by scientists at Harvard University - Fatty Liver
Studies from T. Gunji et al have provided new data on fatty liver - Hepatitis
Recent studies by N. Wang and co-authors add new data to hepatitis findings - Hepatitis B Virus
New findings from X.B. Gu and co-authors in the area of hepatitis B virus published - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
